These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2120489)

  • 1. [Tau protein and beta protein].
    Nukina N
    Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):276-9. PubMed ID: 2120489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biochemistry of alzheimer's disease].
    Hasegawa N; Ihara Y
    Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):119-23. PubMed ID: 1673700
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
    Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
    Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition.
    Tabaton M; Mandybur TI; Perry G; Onorato M; Autilio-Gambetti L; Gambetti P
    Ann Neurol; 1989 Dec; 26(6):771-8. PubMed ID: 2557796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
    Papasozomenos SC
    Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular lesions in Alzheimer's disease: structural and molecular analysis].
    Brion JP
    Bull Mem Acad R Med Belg; 1992; 147(11-12):481-9; discussion 490-1. PubMed ID: 1341572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Abnormal proteins in the brain in Alzheimer's disease].
    Kanemaru K; Ihara Y
    Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):2-11. PubMed ID: 1900947
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuritic pathology and dementia in Alzheimer's disease.
    McKee AC; Kosik KS; Kowall NW
    Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles.
    Bancher C; Brunner C; Lassmann H; Budka H; Jellinger K; Seitelberger F; Grundke-Iqbal I; Iqbal K; Wisniewski HM
    Prog Clin Biol Res; 1989; 317():837-48. PubMed ID: 2557644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.
    Bondareff W; Wischik CM; Novak M; Roth M
    Am J Pathol; 1991 Sep; 139(3):641-7. PubMed ID: 1909492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tau, amyloid and Alzheimer's disease].
    Olesen OF
    Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain site-specific gene expression analysis in Alzheimer's disease patients.
    Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
    Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.
    Shin RW; Ogomori K; Kitamoto T; Tateishi J
    Am J Pathol; 1989 Jun; 134(6):1365-71. PubMed ID: 2502927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of neurofibrillary degeneration in the diagnosis of Alzheimer's disease].
    Gómez-Ramos P; Jiménez A; Cebrián JL; Morán MA
    Med Clin (Barc); 1993 Jun; 101(2):60-3. PubMed ID: 8510479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.
    Kowall NW; Kosik KS
    Ann Neurol; 1987 Nov; 22(5):639-43. PubMed ID: 3122646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
    Joachim CL; Morris JH; Kosik KS; Selkoe DJ
    Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
    Huang HC; Jiang ZF
    J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
    Bramblett GT; Trojanowski JQ; Lee VM
    Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
    Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
    J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.